2024-10-06 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**Company Overview:** Intuitive Surgical Inc. is a leading medical device company that designs, manufactures, and sells robotic-assisted surgical systems.

**Performance Analysis:**

**1.  Performance Compared to S&P 500 (VOO):**

*   **Cumulative Return:** ISRG (344.86%) significantly outperformed VOO (131.01%).
*   **Relative Divergence:** The current relative divergence of 213.85 is 74.03% of the maximum historical divergence (286.92), indicating ISRG’s substantial outperformance compared to VOO historically.

**2. Recent Price Movements:**

*   **Closing Price:** $479.63
*   **5-Day Moving Average:** $484.88
*   **20-Day Moving Average:** $485.53
*   **60-Day Moving Average:** $469.38

The stock is currently trading slightly below its 5-day and 20-day moving averages, suggesting some short-term weakness. However, it’s above the 60-day moving average, indicating potential upside in the longer term.

**3. Technical Indicators:**

*   **RSI:** 40.84, indicating the stock is in a neutral zone, not oversold or overbought.
*   **PPO:** -0.29, suggesting potential for short-term downward pressure.
*   **Delta_Previous_Relative_Divergence:** -2.02, indicating a slight downward trend in the recent 20-day relative divergence.
*   **Expected Return:** 9.0%, representing the estimated maximum 5-year potential return compared to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date       | EPS  | Revenue          |
| ---------- | ---- | ---------------- |
| 2024-07-19 | 1.48 | $2.01 Billion    |
| 2024-04-19 | 1.54 | $1.89 Billion    |
| 2023-10-20 | 1.18 | $1.74 Billion    |
| 2023-07-24 | 1.20 | $1.76 Billion    |
| 2023-04-24 | 1.20 | $1.76 Billion    |

The most recent earnings for Q2 2024 (reported July 19th) surpassed analyst expectations, with EPS of $1.48 exceeding estimates of $1.42 and revenue of $2.01 billion surpassing expectations of $1.99 billion. This indicates strong demand and positive market sentiment for ISRG’s surgical robotic systems.

**5. News and Recent Issues:**

*   **Recent Market Outlook:** The market outlook for ISRG is generally positive, with analysts citing the increasing adoption of robotic surgery and the company's strong market position as key drivers. 
*   **Analyst Opinions:** The majority of analysts maintain a "Buy" or "Outperform" rating on ISRG stock. The average price target is around $525, suggesting significant potential upside from current levels.
*   **Performance Highlights:** ISRG’s strong earnings, coupled with increasing market adoption of robotic surgery, have boosted investor confidence. The company's innovation pipeline, including new product launches and advancements in surgical techniques, continues to drive growth.

**6. Overall Analysis:**

ISRG is a strong performer with a robust track record of outperforming the market. The company’s dominant market share, strong earnings growth, and promising future prospects indicate a positive outlook. While recent price movements suggest some near-term consolidation, the long-term potential remains attractive.

**7. Recommendations:**

*   **Investment Horizon:** Long-term (3-5 years)
*   **Recommendation:** Buy. ISRG is a worthwhile addition to a well-diversified portfolio due to its strong growth potential, market leadership, and future prospects. 
